ATMPs , Biopharmaceuticals & Associated Enabling Technologies

This sub-category within red biotechnology focuses on developing innovative medicines for human use based on genes, tissues or cells, biopharmaceuticals, and technologies that enhance the discovery, development and efficacy of ATMPs and biopharmaceuticals. These all play a key role in advancing personalized medicines, improving patient outcomes and better global healthcare.

In this ATMPs , Biopharmaceuticals & Associated Enabling Technologies Thematic Cluster (TC 3) Biotech Booster connects academia, industry and serial entrepreneurs at an early stage to accelerate the growth of the project teams: to ensure that our society can benefit more quickly from the potential that biotechnology has to offer.

0
Projects
in TC 3
0 M
Funded
0 +
Experts and entrepreneurs

Antimicrobial Nanoparticles

Next generation formulations for RNA

Gelion Care

Macrophage Liposomes

EV antibodies for the treatment of cancer

T-Guard

Discover our program

Are you an entrepreneur or scientist looking to bring your idea or technology to the market? Our program offers mentorship, financial support and networking opportunities, to guide founders from the idea stage to developing an investable and commercial proposition. 

Molecuul

Meet our TC3 team

Ranja Wabeke

Jessie van Buggenum

TC 3 Manager

Joyce Boudewijns

Business Developer TC 3

Jasper Dijkstra

Business Developer TC 3

Marleen Kristen

Business Developer TC 3

Annemieke van der Goot

Impact Developer TC3

Valeria Saar-Kovrov

Business Developer TC 3

Sanja Stevanovic

Business Developer TC3

Lieve van Veggel

Business Developer TC 3

Rick Meurders

Business Developer TC 3

Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Moleculen

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter